News Conference News TCT 2022 FAVOR III China: Early Gains of QFR in PCI Persist to 2 Years L.A. McKeown September 20, 2022
Presentation TCT 2022 Current Medical Therapy Is the Gold Standard for Plaque Stabilization Presenter: David J. Cohen September 18, 2022
News Daily News COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK Michael O'Riordan September 15, 2022
News Conference News TCT 2022 New Faces, New Formats, New Tech: What to Expect From TCT 2022 Shelley Wood September 07, 2022
News Daily News Longer-Term Data Still Worrisome for Impella-Treated AMICS Patients Caitlin E. Cox July 20, 2022
Presentation Fellows 2022 The Evolution in PCI Pharmacology Over the Past 25 Years Presenter: David Cohen May 06, 2022
Presentation Fellows 2022 Top 10 Interventional Cardiology Trials You Need to Know Presenter: David Cohen May 06, 2022